Four-year-old Jakub from Hull and three-year-old Rufus from Bridlington are at increased risk of serious chest infections ...
Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 ...
Long-term use of the triple-drug therapy allows many individuals with cystic fibrosis to maintain stable health even after ...
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the ...
Researchers have found in a new study that triple CFTR modulator therapy, or elexacaftor/tezacaftor/ivacaftor (ETI), produces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results